期刊文献+

MMR蛋白在云南地区遗传性非息肉病性大肠癌中的表达及意义 被引量:5

Expression of MMR Proteins in Hereditary Nonpolyposis Colorectal Cancer in Yunnan Region
下载PDF
导出
摘要 目的探讨MLH1、MSH2、PMS2和MSH6蛋白在云南地区遗传性非息肉病性大肠癌(heredi-tary nonpolyposis colorectal cancer,HNPCC)中的表达及意义。方法根据目前国内外通常采用的三个标准在云南地区选择遗传性非息肉病性大肠癌病例13个家系中19例肿瘤组织,应用免疫组织化学方法(I HC)检测MLH1、MSH2、PMS2和MSH6蛋白。结果在这13个家系中,MLH1、MSH2、PMS2和MSH6四种蛋白表达缺失率分别为30.77%、38.46%、23.08%、15.38%,其中2例家系先证者同时存在MLH1和PMS2蛋白表达缺失,2例家系先证者同时存在MSH2和MSH6蛋白表达缺失,四种MMR蛋白总的表达缺失率为84.62%。结论云南地区HNPCC病例存在MLH1、MSH2、PMS2和MSH6四种MMR蛋白不同程度的缺失表达,应用I HC检测MMR蛋白可以作为筛选HNPCC家系的一有效手段。 Objective To evaluate the significance of the expression of MLH1,MSH2,PMS2 and MSH6 proteins in hereditary non polyposis colorectal cancer cases in Yunnan region.Methods Using current three criteria commonly used in China and abroad to select HNPCC 19 tumor tissue cases from 13 families in Yunnan region,and these tumor tissue were assessed by immunohistochemical detection of MLH1,MSH2,PMS2 and MSH6 proteins.Results In the 19 tumor tissues cases,the expression loss rates of MLH1,MSH2,PMS2 and MSH6 proteins were 30.77%,38.46%,23.08% and 15.38% respectively.And in these case of absent of MMR protein,2 cases were lost MLH1 and PMS2 proteins at the same time;3 cases lost MSH2 and MSH6 at the same time.The total expression loss rates of four MMR proteins was 84.62%.Conclusion The suspected HNPCC cases in the Yunnan region had loss of expression of the MMR(MLH1,MSH2,PMS2,MSH6).The immunohistochemical detection of MMR proteins can be used as an effective technique in screening HNPCC pedigrees.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第3期270-273,共4页 Cancer Research on Prevention and Treatment
基金 云南省社会发展科技计划基金资助项目(2007CA009)
关键词 结直肠肿瘤 遗传性非息肉病性 错配修复蛋白 免疫组织化学 Colorectal neoplasms Hereditary nonpolyposis Mismatch repair protein Immunohistochemistry
  • 相关文献

参考文献12

  • 1Jeremy R Jass.Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term[J].World Journal of Gastroenterology,2006,12(31):4943-4950. 被引量:24
  • 2金黑鹰,崔龙,孟荣贵,喻德洪,阎于悌,徐洪莲,刘飞.遗传性非息肉病性结直肠癌家族多原发癌的特点[J].中华胃肠外科杂志,2001,4(3):165-166. 被引量:15
  • 3Shia J,Vakiani E,Guillem J,et al.Immunohistochemistry(IHC)as first-line screening tool for detecting colorectal canc-er(CRC)patients at risk for Lynch syndrome:a2-antibodypanel is as predictive as a4-antibody panel(Abstr). ModPathol . 2008
  • 4Jones PA,Laird PW.Cancer epigenetics comes of age. Nature Genetics . 1999
  • 5Leach F S,Polyak K,Burrell M,et al.Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Research . 1996
  • 6Peltomaki P,Vasen H.Mutations associated with HNPCC predisposition-Update of ICG-HNPCC/INSiGHT mutation database. Disease Markers . 2004
  • 7Ramsoekh D,Wagner A,van Leerdam ME, et al.A high incidence of MSH6 mutations in Amsterdam criteria Ⅱ-negative families tested in a diagnostic setting. Gut . 2008
  • 8A Wagner,Y Hendriks,EJ Meijers-Heijboer,WJ Leeuw,H Morreau,R Hofstra,C Tops,E Bik,AH Brocker-Vriends,C Meer.Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. Journal of Medical Genetics . 2001
  • 9L Senter,M Clendenning,K Sotamaa.The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology . 2008
  • 10R.C. Niessen,J.H. Kleibeuker,H. Westers.PMS2 involvement in patients suspected of Lynch syndrome. Genes Chromosomes and Cancer . 2009

二级参考文献8

  • 1Lynch HT,Lynch JF.Hereditarynonpolyposis coloretal cancer.Semin Surg Oncol,2000,18:305-313.
  • 2Vasen HF,Mecklin JP,Khan PM,et al.The international collaborative group onhereditary nonpolyposis colorectal cancer(ICG HNPCC).Dis Colon Rectum,1991,34:424-425.
  • 3Kunitomo K.HNPCC in Japan.J Jpn Soc Colotproctol,1993,46:475-479.
  • 4Ziogas Fox EA,Gildea M,et al.Characterization of hereditary nonpoly posis coloretalcnacer families from a population based series of cases.J Natl CancerInst,2000,92:1517-1522.
  • 5Tomoda H,Baba H,Taketomi A,et al.Second primary extracolonic cancers in Japanesehereditary nonpolyposis colorectal cancer.Oncol Rep,1998,5:143-145.
  • 6Myrhoj T,Bisgaard ML,Bernstern LB,et al.Hereditary nonpolyposis colorectalcancer:cilinical features and survivals:Results from the Dannish HNPCC Register.Scand JGastroenterol,1997,32:572-576.
  • 7Soravia C,Berk T,Cohen Z.Genetic testing and surgical decision making in hereditarycolorectal cancer.Int J Colorectal Dis,2000,15:21-28.
  • 8Yong-Mao Song Department of Oncology,2nd Affiliated Hospital,Medical College,Zhejiang University,Hangzhou 310009,Zhejiang Province,China Shu Zheng Cancer Institute,Zhejiang University,Hangzhou 310009,Zhejiang Province,China.Analysis for phenotype of HNPCC in China[J].World Journal of Gastroenterology,2002,8(5):837-840. 被引量:5

共引文献35

同被引文献51

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部